Acute ventricular fibrillation and death during infusion of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA).
D000328:Adult; D000609:Aminoacridines / Q000008:administration & dosage / Q000009:adverse effects*; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D000609:Aminoacridines; D000970:Antineoplastic Agents; D000677:Amsacrine